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NC-ND license (http://creativecommoSummary Background/objective: Uncontrolled surgical bleeding is associated with
increased morbidity, mortality, and hospital cost. Topical hemostatic agents available today
have problems controlling hemostatic effects; furthermore, their handling is difficult and they
are unsafe.
Methods: We devised a new hemostatic agent comprising gelatin sponge and film designed to
be applied to the bleeding site, thereby creating a topical hemostatic agent made of gelatin
alone. The gelatin was prepared by alkali treatment to eliminate viral activity. Hemostatic ef-
fects, surgical handling, and tissue reactions of the materials, namely a two-layer sheet of
gelatin, TachoSil, and gelatin sponge, were evaluated using 21 dogs’ spleens.
Results: The two-layer gelatin sheet and gelatin sponge exhibited superior hemostatic effects
(100% hemostasis completed) compared with TachoSil (0e17% hemostasis). The gelatin matrix
immediately absorbed blood flowing from wounds and activated the autologous components in
the absorbed blood that promoted coagulation at the bleeding site. The two-layer gelatin
sheet had the best surgical handling among the evaluated materials. Materials made of gelatin
were associated with fewer inflammatory reactions compared with materials of TachoSil.
Conclusion: The two-layer sheet of gelatin is a useful topical agent because of its superior he-
mostatic effects and usability, and is associated with a lower risk of transmitting diseases and
inflammatory reactions.
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Figure 1 Two-layered gelatin sheet.
2 T. Takagi et al.
+ MODEL1. Introduction
To control bleeding during surgery, conventional proced-
ures such as ligation, direct compression, electro-
cauterization, and clipping are used. Topical hemostatic
agents are available for treating oozing blood or bleeding
from regions difficult to access by conventional methods.
Uncontrolled surgical bleeding is associated with increased
morbidity and mortality, higher hospital costs, and post-
operative adhesions and infections.1e3 Blood transfusions
increase the risk of postoperative complications and have
safety issues. Various hemostatic agents have been devel-
oped,3e7 but improvement is needed in terms of efficacy,
ease of handling, and safety, especially during laparoscopic
surgery.
Among hemostatic materials, TachoSil (CSL Behring, King
of Prussia, PA, USA) is a ready-to-use agent that comprises
an equine collagen matrix coated with human fibrinogen
and human thrombin. TachoSil is widely used in many sur-
gical specialties and has proven to be a valuable tool for
several indications.6,8,9 TachoSil has shown clinical superi-
ority in terms of hemostatic efficacy, duration of hospital
stay, and postoperative utility for hepatic, cardiac, renal,
lung, and pancreatic surgeries compared with conventional
surgical procedures.10e14 However, TachoSil has problems
with intraoperative handling, especially at sites that are
difficult to access, and is associated with higher risks of
viral infection, other transferable diseases, and allergic
reactions resulting from human hemostatic components.2
To address the abovementioned problems, hemostatic
agents that are safe and easy to handle and have sufficient
hemostatic effects are needed. Gelatin-based hemostatic
agents with or without fibrin components may be used
during surgery15e17 However, the hemostatic effects of
gelatin matrix are controversial compared with other
topical hemostatic agents6 Gelatin-based agents without
fibrin or thrombin components may be able to solve the
problems mentioned above when usability is improved. In
the present study, gelatin almost completely eliminated
immunogenicity and viral activity by alkali treatment.
The remainder of this article describes the utility of a
newly developed topical hemostatic agent, two-layer sheet
of gelatin. TachoSil and the new product were compared in
splenic injuries in which hemostasis is not easily achieved.
2. Materials and methods
2.1. Preparation of hemostatic agents
2.1.1. Two-layer sheet of gelatin
Low endotoxin gelatin extracted from porcine skins (Type-I
collagen, Medigelatin) with an isoelectric point of 5 was
supplied by Nippi Co. Ltd. (Tokyo, Japan). The gelatin was
dissolved in distilled water to concentrations of 1.0 wt% and
4.8 wt%. The gelatin 4.8 wt% solution was cast onto a
polystyrene Petri dish (nontissue-culture treated; Corning
Inc., Tokyo, Japan) and dried overnight on a clean bench at
room temperature. The obtained film was slightly cross-
linked by exposure to UV light for 2 minutes. The gelatin 1.0
wt% solution was cast onto a gelatin film on a Petri dish and
placed in a deep freezer (MDF-U53V; SANYO Electric Co.,Please cite this article in press as: Takagi T, et al., Two-layer sheet of
(2016), http://dx.doi.org/10.1016/j.asjsur.2016.09.007Osaka, Japan) at 80C for 30 minutes; it was then freeze
dried for 24 hours in a vacuum freeze dryer (DRZ350WA;
Advantec, Tokyo, Japan) in order to make a gelatin sponge.
After freeze drying, a two-layered gelatin sheet composed
of gelatin film and sponge layers was removed from the
Petri dish and dehydrothermally cross-linked in a vacuum
oven (DP41; Yamato Scientific Co. Ltd., Tokyo Japan) at
140C for 3 hours. The two-layer sheet of gelatin was cut
into square sheets of 30 mm 30 mm immediately before
use (Figure 1).
2.1.2. TachoSil
TachoSil, which is composed of collagen matrix, fibrinogen,
and thrombin was used in accordance with the manufac-
turer’s instructions. TachoSil was cut into square sheets
measuring 30 mm 30 mm immediately before use.
2.1.3. Gelatin sponge
A gelatin sponge was prepared using the same methods
outlined above as a two-layer sheet of gelatin without un-
dergoing the process to create a gelatin film (i.e., only a
matrix made of sponge layer was used). After freeze drying,
the gelatin sponge sheet was removed from the Petri dish
and dehydrothermally cross-linked in a vacuum oven (DP41;
Yamato Scientific Co. Ltd.) at 140C for 3 hours. The gelatin
sponge sheet was cut into square sheets measuring
30 mm 30 mm immediately before use.
2.2. Design of animal experiments
The animal experiments performed in this study were
approved by the Doshisha University Animal Experimenta-
tion Committee. All animal care, housing, and surgical and
anesthetic procedures were performed in accordance withgelatin: A new topical hemostatic agent, Asian Journal of Surgery
Figure 2 Schematic diagram of the experiment.
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Research of Doshisha University, Nara Medical University
and European Commission Directive 86/609/EEC for animal
experiments.
Twenty-one nonpregnant, female, 2-year-old beagles
weighing 9.5e10.5 kg were purchased from Shimizu Lab-
oratory Animal Supply Co. Ltd. (Kyoto, Japan). During the
experimental period, all dogs were housed separately and
maintained under standard conditions (a lightedark cycle
of 12:12 hours, mean temperature of 23C, and mean
humidity of 50%). Standard laboratory dog chow and
water were freely available. Before the study, the dogs
were housed in the laboratory for 1 week. On the 1st day
of the experiment, the health condition of all dogs was
assessed.
2.3. Surgical procedure to evaluate the effects of
hemostatic agents
All surgeries were performed under sterile conditions, by a
team of three persons. The dogs were randomly assigned to
one of three groups corresponding to each hemostatic
material. Eighteen dogs were anesthetized with intrave-
nous sodium pentobarbital (Somnopentyl Kyoritsu Seiyaku,
Tokyo, Japan; 34 mg/kg). A 12-cm epigastric median inci-
sion was made. The surface of the upper or lower part of
the spleen was reduced with scissors to 1e2 mm in depth
and 20 mm 10 mm in area and allowed to bleed. Imme-
diately after wiping blood from the spleen with gauze, one
of three hemostatic materials (2-layer sheet of gelatin,
TachoSil, gelatin sponge) was applied over the cut surface.
Then, the hemostatic material was covered with gauze and
digital pressure applied over it for 1 minute or 5 minutes;
the gauze was removed gently so that immediate bleeding
and rebleeding (bleeding after bleeding had stopped) could
be observed during a 5-minute observation period. The
physical status of the dogs remained stable during surgery.
To exclude arbitrary procedure by operators or differences
of conditions among experimental groups, the operators
were blinded to the material being applied until astriction.
Random study was scheduled for the experiments. This
experiment was performed on six dogs for each hemostatic
material. The time of rebleeding was recorded for each
material.
Hemostatic effects were evaluated during an observa-
tion period of 5 minutes because the standard range in
clinical tests using Duke’s method is 1e5 minutes bleeding
time. When blood was observed flowing out of the materials
during the observation period, hemostasis was assessed as
having been broken (rebleeding) and the time of rebleeding
was recorded (Figure 2). The hemostatic materials were
also evaluated for handling and ease of use during surgery.
2.4. Histological observation of implanted material
and surrounding tissues
In order to observe histological change at the site of
astriction, we examined three other dogs. The surfaces of
the dogs’ spleens were shaved to a size of 1 cm 1 cm
under general anesthesia, and bleeding was confirmed;
astriction was performed for 1 minute with gauze. One ofPlease cite this article in press as: Takagi T, et al., Two-layer sheet of
(2016), http://dx.doi.org/10.1016/j.asjsur.2016.09.007the three hemostatic agents was then applied to the wound
and pressed for >5 minutes with gauze over the material.
After hemostasis was confirmed, the abdomen was closed.
The whole spleens were excised 2 weeks after the initial
operation under inhalation anesthesia. The parts of the
spleen that had been covered with each hemostatic ma-
terial were resected, fixed with formalin, and stained with
hematoxylin and eosin. The tissue response to the materials
and residues of the hemostatic materials were observed.
2.5. In vitro experiments for absorbency and
permeability
The absorbency and permeability of each hemostatic ma-
terial was evaluated using canine blood. Hemostatic ma-
terials were cut into 1 cm 1 cm squares. Single drops of
80 mL blood were placed by pipette on the hemostatic
materials from a height of 1 cm. Absorption time was
recorded as the time when the droplet disappeared from
the material surface. Permeability was recorded as the
time when the blood was exuded onto the material base.
2.6. Statistical analysis
The data are expressed as the mean standard deviation.
Statistical analyses were carried out using the Krus-
kaleWallis test and the chi-square test with Stat/Mate III,
Windows (ATMS Co., Tokyo, Japan). A p value< 0.05 was
considered statistically significant.
3. Results
3.1. Hemostasis effects in animal experiments
Table 1 shows the results for the three groups of hemostatic
agents. In the TachoSil group, hemostasis was not achieved
in three of six spleens after a minute’s duration of
compression of the bleeding site. In all the other spleens
applied with TachoSil, rebleeding was observed during the
5-minute observation period after decompression. With
respect to the other two groups, initial hemostasis was
achieved after a minute of astriction and rebleeding was
not seen in any of the six spleens during the observation
period. There were significant differences between the
TachoSil group and the two other groups (p< 0.001).
In all groups, hemostasis was successfully achieved after
5 minutes of compression. In five of six spleens in thegelatin: A new topical hemostatic agent, Asian Journal of Surgery
Table 1 Comparison of the hemostatic effects of TachoSil, a two-layer sheet of gelatin, and a gelatin sponge in bleeding dog
spleens.
Hemostatic material Positive for bleedinga/
total experiments
Positive for rebleedingb/
total experiments
Positive for bleedingaþb/total experiments
Compression time 1 min 5 min 1 min 5 min 1 min 5 min
Two-layer
sheet of gelatin
0/6 0/6 0/6 0/6* 0/6 * 0/6 *
TachoSil 3/6 0/6 3/6 5/6 6/6 5/6
Gelatin sponge 0/6 0/6 0/6 0/6* 0/6 * 0/6 *
* p< 0.001; significantly different compared with TachoSil.
a Bleeding just after 1 minute or 5 minutes of compression.
b Rebleeding occurred during the 5-minute observation period after 1 minute or 5 minutes of compression.
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In gelatin sheet and gelatin sponge groups, there was no
rebleeding observed throughout the observation period
(Table 1).
3.2. Absorbency and permeability of materials
in vitro
The absorbency of the two-layer gelatin sheet (104 115
seconds) and the gelatin sponge (277 117 seconds) were
significantly higher than that of TachoSil (>360 seconds;
p< 0.05). Both the two-layer gelatin sheet and TachoSil
had significantly (p< 0.05) low permeability (333 61
seconds, > 360 seconds, respectively). The gelatin sponge
had high permeability. That meant the two-layer sheet of
gelatin had high absorbency and low permeability
(Figure 3).
3.3. Usability of the materials during surgery
Blood from the spleen surface infiltrated the TachoSil and
gelatin sponge and reached the compression gauze. The
two kinds of gelatin preparations showed good adhesive
properties because their sponge layer became an adherent
gel after absorbing blood. By contrast, TachoSil was less
adhesive after being soaked in blood and showed no gelFigure 3 Absorbency and permeability of the materials.
Please cite this article in press as: Takagi T, et al., Two-layer sheet of
(2016), http://dx.doi.org/10.1016/j.asjsur.2016.09.007formation. The gel layer, composed of gelatin sponge and
blood, attached tightly to the compression gauze, but it
became difficult to remove the gauze from the material
surface in the gelatin sponge group. However, the gelatin
“film” layer was impermeable, and the blood from the
wound did not reach the compression gauze. It was easy to
detach the gauze without removing the gelatin sheet from
the wound (Figure 4).
3.4. Histological findings regarding embedded
materials
There was strong invasion of inflammatory lymphocytes
noted in the injured part of the spleen embedded with
TachoSil. The collagen materials of TachoSil still remained
for 2 weeks. In the gelatin groups, inflammatory change
was absent (Figure 5) and reepithelization was observed in
2 weeks. The gelatin materials were absorbed almost
completely in 2 weeks. The wound healing in gelatin group
was better than in TachoSil group.
4. Discussion
Our experiments showed that the two-layer sheet of gelatin
has superiority over TachoSil in terms of hemostatic ef-
fects, utility, and safety in canine experiments.
4.1. Hemostatic effect
Topical hemostatic agents are used for the control of
bleeding during surgery. Among the topical agents avail-
able, TachoSil has been shown to have superior hemostatic
effects in various kinds of surgery.9,11e14,18 By contrast,
TachoSil was less effective in sites where a relatively large
quantity of bleeding was seen because of weak adhesion to
the bleeding site.9 The hemostatic effect of gelatin matrix
is still controversial,3,7,15,19,20 but most of the studies we
found showed that gelatin had a poor hemostatic effect
compared with TachoSil. This prompted us to develop a
two-layer sheet of gelatin to solve these problems.
The physical properties of gelatin matrix contribute to
superior hemostatic effects compared with collagen matrix
(TachoSil). In our study, the gelatin sponge layer smoothly
and rapidly absorbed blood and activated autologous blood-gelatin: A new topical hemostatic agent, Asian Journal of Surgery
Figure 4 Hemostatic agents set onto the shaved surface of
the spleen. (A) Two-layer sheet of gelatin. (B) TachoSil. (C)
Gelatin sponge.
Figure 5 Histologic findings regarding embedded materials.
(A) Two-layer sheet of gelatin. (B) TachoSil. (C) Gelatin sponge.
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matrix changed to gel, which covered bleeding sites tightly.
Moreover, the gelatin film layer of the two-layer gelatin
sheet inhibited the permeation of blood, consequentlyPlease cite this article in press as: Takagi T, et al., Two-layer sheet of
(2016), http://dx.doi.org/10.1016/j.asjsur.2016.09.007strengthening adhesive bonding to the bleeding site. By
contrast, the reduced permeability of the collagen sponge
probably permitted continuous bleeding from the site, and
subsequent bleeding or oozing disturbed the hemostatic
effects of fibrinogen and thrombin because of the blood
flowing out. The two-layer sheet of gelatin absorbed bloodgelatin: A new topical hemostatic agent, Asian Journal of Surgery
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thereby allowing fibrin to bind the sheet and wound tightly.
After hemostasis was completed, the hemostatic effects
were not necessary. The thickness of the two-layer sheet of
gelatin was thought to be enough to stop bleeding in this
study. However, TachoSil absorbed flowing blood more
slowly and coagulation inside TachoSil and on the surface of
the material took longer to complete. Regarding the
rebleeding, flexibility and adherence of the materials were
thought to be more important than absorbency. The two-
layer sheet of gelatin’s ability to follow the shape of the
wound surface is superior to that of TachoSil. The gelatin
sheet can adhere to the tissue tightly after compression,
but TachoSil leaves a small gap after astriction. Rebleeding
can occur from a gap between the material and the wound.
In our study, we set the time for manual compression at
1 minute or 5 minutes to compare the different hemostatic
materials. In past studies, compression time was set at
longer than 3 minutes. Compared with the other materials,
the initial hemostasis of TachoSil took longer and was
incomplete, resulting in more frequent instances of
rebleeding. The two-layer sheet of gelatin required a
shorter time to complete hemostasis and the hemostatic
effects were so secure that no rebleeding was found in any
of the spleens tested. Overall, the hemostatic effect of the
two-layer sheet of gelatin appears to be superior to
TachoSil in sites where a relatively large quantity of
bleeding is seen (e.g., spleen, pelvic floor, blood flow-rich
parenchymal organs).7,21,22 In the present study, we eval-
uated the hemostatic effects of three materials on a
bleeding parenchymatous organ where bleeding is notori-
ously difficult to control. Conventional techniques for he-
mostasis and TachoSil are effective in cases where there is
a small amount of bleeding and in sites where bleeding is
easy to control. A two-layer sheet of gelatin is a possible
choice for hemostasis in cases where there is a relatively
large amount of bleeding.
4.2. Handling
The nonadhesive property of a gelatin “film” layer works
more effectively to prevent bleeding immediately after the
release of gauze compression. TachoSil and the gelatin
sponge have a permeable layer and thus are disadvanta-
geous for surgical handling because strong adhesion to
compression gauze is more likely with the contact of blood
and gauze, which may induce rebleeding after detachment.
TachoSil is probably effective in cases where blood does not
reach the compression gauze. The two-layer gelatin sheet
and TachoSil present problems for laparoscopic surgery
because they are both difficult to place into the abdominal
cavity through a port. Gelatin materials must undergo re-
finements in order to be suitable for laparoscopic surgery.
We are reforming gelatin materials for use during laparo-
scopic surgery.
4.3. Safety
Hemostatic agents remain in the body after surgery,
therefore, long term safety is a very important issue.
Excessive inflammatory response of the tissue byPlease cite this article in press as: Takagi T, et al., Two-layer sheet of
(2016), http://dx.doi.org/10.1016/j.asjsur.2016.09.007hemostatic materials can cause adhesion. Moreover, long
term residues of the material possibly make the risk of
infection higher. In the present study histological exami-
nation was carried out in order to observe the tissue
response to the each material, not to examine the hemo-
static effects of each material. Earlier regeneration of the
peritoneum and earlier absorption of the material were
observed in two-layer gelatin sheet. However, TachoSil
induced intensive inflammatory response at the implanted
site and remained longer than the gelatin sheet. Regarding
adhesion, two-layer sheet of gelatin is possibly safer than
TachoSil.23e25 In our unpublished study (under submission)
the two-layer gelatin sheet has an antiadhesive effect due
to early regeneration of the peritoneum and mild inflam-
matory response.
The two-layer gelatin sheet, which is composed of
alkaline-treated gelatin, does not carry the same risks as
biomaterials (TachoSil), such as transmission of viral
infection and allergic reactions. In fact, the gelatin alkali-
treatment process eliminates the risk of transmittable
diseases almost completely.26 Moreover, from the skin of
animals, infectivity of Bovine Spongiform Encephalopathy
was not detected.
5. Conclusion
We showed that the two-layer gelatin sheet is a more
effective, easier to handle, and safer topical hemostatic
agent than TachoSil, which is one of the most popular
materials currently in use. The two-layer sheet of gelatin is
safer than topical agents including fibrin components and/
or thrombin in terms of risk of viral transmission and in-
flammatory reactions. We showed the hemostatic effec-
tiveness of a two-layer sheet of gelatin in bleeding dog
spleens (an organ where bleeding is difficult to control).
The efficacy of newly developed materials should be eval-
uated by application to other organs (liver, kidney, lung,
and vessels) and in humans.
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